# A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

> **NCT06123663** · PHASE1 · COMPLETED · sponsor: **CanSino Biologics Inc.** · enrollment: 60 (actual)

## Conditions studied

- Tetanus

## Interventions

- **BIOLOGICAL:** TTVA
- **BIOLOGICAL:** TT

## Key facts

- **NCT ID:** NCT06123663
- **Lead sponsor:** CanSino Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-20
- **Primary completion:** 2024-01-23
- **Final completion:** 2024-06-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06123663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06123663, "A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06123663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*